Discovery and Toxicologic Pathology
Ensigna Biosystems uses a network of experienced in-house and consultant pathologists to perform discovery and toxicologic pathology. We provide extensive characterization of laboratory animal models. This includes full histopathological, immunohistochemical and gene expression evaluation when appropriate.
We also perform safety evaluation and assess adverse drug effects in early and late stages of drug discovery. A complete histopathological examination of FDA tissue panel with tables of frequency and severity of lesions can be provided. We can apply our IHC expertise to assess tissue distribution of biologics.